JOS Pharmaceuticals

Curated by Signal

Developer of oro-mucosal drug delivery technology for anesthesia care

Overview

Developer of oro-mucosal drug delivery technology for anesthesia care. By using Catalent’s proprietary Zydis orally disintegrating tablet (ODT) technology the company has developed a cannabidiol (CBD) product for use as an anesthetic premedication.

Key facts

Founded: 2021
Headquarters: United States
Stage: Sign up to view
Industry: Health Technology

Business model

1 product or service: Sign up to view

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Lolo
Provider of an application for fitness training
Health TechnologySalt Lake City, United States
Grove Biopharma
Developer of AI-based drug modality platform for protein-based drugs
Health TechnologySeattle, United States
Geno.Me
Online platform offering data mining tools for gene analysis
Health TechnologyMilwaukee, United States

About JOS Pharmaceuticals

What does JOS Pharmaceuticals do?

Developer of oro-mucosal drug delivery technology for anesthesia care.

Where is JOS Pharmaceuticals headquartered?

JOS Pharmaceuticals is headquartered in United States.

When was JOS Pharmaceuticals founded?

JOS Pharmaceuticals was founded in 2021.

Which sector is JOS Pharmaceuticals in?

JOS Pharmaceuticals operates in Health Technology.

Who are JOS Pharmaceuticals's competitors?

Companies similar to JOS Pharmaceuticals include Lolo, Grove Biopharma, and Geno.Me.